MRVIMaravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
Sector Update: Healthcare Stocks Fall Late Afternoon Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index decreasing 0.9% a | MMT Newswires | |
 Maravai (MRVI) Q2 2026 Earnings Call Transcript Revenue grew 8.5% to $51.4 million as mRNA discovery demand surged. | ||
 Maravai LifeSciences Holdings, Inc. Q2 2026 Earnings Call Summary Moby summary of Maravai LifeSciences Holdings, Inc.'s Q2 2026 earnings call | ||
 Maravai LifeSciences Q2 Earnings Call Highlights Maravai LifeSciences (NASDAQ:MRVI) reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its adjusted EBITDA forecast. Revenue for the quarter was $51.4 million, up 9% from the prior-year period. CE | ||
 Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates Maravai LifeSciences (MRVI) delivered earnings and revenue surprises of +60.00% and +4.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
IInsider Monkey | ||